Status: current, Defined. Date: 31-Mar 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2483721000168116 | Tasigna (nilotinib 150 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2483731000168118 | Tasigna 150 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tasigna 150 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Tasigna 150 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 565697609 | |
| Tasigna 150 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tasigna 150 mg capsule | Is a | Tasigna | true | Inferred relationship | Some | ||
| Tasigna 150 mg capsule | Is a | nilotinib 150 mg capsule | true | Inferred relationship | Some | ||
| Tasigna 150 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Tasigna 150 mg capsule | has intended active ingredient | nilotinib | true | Inferred relationship | Some | 565697608 | |
| Tasigna 150 mg capsule | has Australian BoSS | nilotinib | true | Inferred relationship | Some | 565697608 |
Reference Sets
Trade product unit of use reference set
FHIR